Balsm Alofoq rejects new auditor appointment

Logo of Balsm Alofoq Medical Co.

Balsm Alofoq Medical Co.’s shareholders disapproved the appointment of an auditor to review and audit the company’s preliminary financial statements for H1 2025, FY 2025, and H1 2026, in addition to setting his fees.
 
 

This came during the extraordinary general meeting (EGM) held on June 22, according to a statement to Tadawul.

 

Other agenda items were approved, and the board of directors was authorized to distribute interim dividends on a semi-annual or quarterly basis for 2025, the statement added.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request